The first generation of tau tracers, most notably the radiopharmaceutical [18F]-FAV1451 (formerly [18F]-T807 and commercially known as [18F]-Flortaucipir), has affinity only for 3R/4R helical tau filaments, which are exclusive to AD. This evidence concerns the gene MAPT and Alzheimer disease.